Sputnik V is the world’s first registered COVID-19 vaccine with proven 91.6% efficacy, based on a human adenoviral vector platform. Registered in over 70 countries.
Company Details
- Address
- The Russian Direct Investment Fund (Rdif) Capital City, South Tower, 7th, 8th Floor, 8 Bld. 1 Presnenskaya Nab. Moscow, Russia, Moscow,123112,russian Federation
- Industry
- Research
- Website
- https://sputnikvaccine.com
- HQ
- Moscow
Sputnik V Questions
Sputnik V's website is https://sputnikvaccine.com
Sputnik V's LinkedIn profile is https://ru.linkedin.com/company/sputnik-vaccine
Sputnik V's industry is
Research
Sputnik V's top competitors are
Johnson & Johnson,
Iyno,
Astrazeneca,
Sinovac Biotech Ltd.,
Wiv France,
Kommersant,
Russia News,
Globalnest,
Sputnik Media,
Pfizer.
Sputnik V's categories are Research
